US 12247973
Plasma membrane citrate transporter for use in the diagnosis and treatment of cancer
granted A61KA61K2039/505
Quick answer
US patent 12247973 (Plasma membrane citrate transporter for use in the diagnosis and treatment of cancer) held by UNIVERSITÄTSKLINIKUM REGENSBURG expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- UNIVERSITÄTSKLINIKUM REGENSBURG
- Grant date
- Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/505